Susquehanna International Group’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.74M Buy
47,073
+12,957
+38% +$703K ﹤0.01% 5463
2025
Q4
$1.57M Sell
34,116
-84,618
-71% -$3.78M ﹤0.01% 6132
2025
Q3
$4.28M Sell
118,734
-34,118
-22% -$1.13M 0.01% 4345
2025
Q2
$4.97M Sell
152,852
-165,486
-52% -$5.42M 0.01% 3981
2025
Q1
$12M Buy
318,338
+192,942
+154% +$15.4M 0.02% 2294
2024
Q4
$10.3M Buy
125,396
+80,926
+182% +$8.04M 0.02% 2631
2024
Q3
$5.08M Buy
44,470
+20,343
+84% +$1.83M 0.01% 3563
2024
Q2
$1.82M Sell
24,127
-19,684
-45% -$1.34M ﹤0.01% 5275
2024
Q1
$2.99M Buy
43,811
+13,113
+43% +$908K ﹤0.01% 4522
2023
Q4
$1.93M Buy
30,698
+8,993
+41% +$467K ﹤0.01% 5436
2023
Q3
$1.11M Sell
21,705
-5,684
-21% -$280K ﹤0.01% 6409
2023
Q2
$1.37M Sell
27,389
-63,216
-70% -$3M ﹤0.01% 5971
2023
Q1
$3.4M Buy
90,605
+74,647
+468% +$3.17M 0.01% 4074
2022
Q4
$765K Sell
15,958
-27,498
-63% -$1.08M ﹤0.01% 6767
2022
Q3
$1.04M Sell
43,456
-19,375
-31% -$491K ﹤0.01% 6531
2022
Q2
$1.37M Buy
62,831
+47,071
+299% +$1.09M ﹤0.01% 5770
2022
Q1
$381K Sell
15,760
-4,384
-22% -$95.8K ﹤0.01% 9669
2021
Q4
$479K Buy
20,144
+5,378
+36% +$125K ﹤0.01% 9324
2021
Q3
$375K Sell
14,766
-4,170
-22% -$101K ﹤0.01% 10080
2021
Q2
$426K Buy
+18,936
New +$388K ﹤0.01% 9968
2021
Q1
Hold
0
12802

Other funds holding PCVX